{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1.98 vs. cons $1.92",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "General Insurance calendar-year combined ratio (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~88.0% vs. cons ~89.3%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "General Insurance NPW growth, constant-dollar (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~16% vs. cons ~13%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS outlook",
      "prediction": "BETTER",
      "answer": "guide ~$8.10 vs. cons $8.00 (FY2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "FY2026 General Insurance NPW growth guidance",
      "prediction": "BETTER",
      "answer": "guide ~mid-teens 15% vs. cons low-to-mid-teens 12% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Other Operations core NII guide (Q3 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$35M vs. cons $35M (Q3 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 2.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A likely EPS/combined-ratio beat plus reiterated-or-raised FY26 NPW growth guidance and accelerated buyback (Corebridge proceeds now fully deployable) should push consensus EPS revisions higher over the following days rather than fade, since the out-period math (Everest/Convex accretion continuing, expense ratio structurally below 30%, dividend growth) supports durable estimate upgrades; the main fade risk is if property-market softness/casualty reserve commentary reintroduces mix-shift concerns, but base case is follow-through given the multi-quarter beat streak and improving capital-return story.",
  "day5_confidence": "MEDIUM"
}